We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pharsight and FDA Collaborate on Critical Path Initiative

News   Jun 13, 2006

 
Pharsight and FDA Collaborate on Critical Path Initiative
 
 
 

RELATED ARTICLES

Collaboration Aims To Improve Efficacy of Lung Cancer Drug

News

The University of Barcelona and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug used to treat lung cancer.

READ MORE

Directing Self-propelled Protocells To Deliver Drugs

News

Synthetic protocells can be made to move toward and away from chemical signals, an important step for the development of new drug-delivery systems that could target specific locations in the body.

READ MORE

Single Low-dose of Intravenous Ketamine Relieves Depressive Symptoms With Mild Side Effects

News

National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE